Literature DB >> 12754704

Single base substitutions at the initiator codon in the mitochondrial acetoacetyl-CoA thiolase (ACAT1/T2) gene result in production of varying amounts of wild-type T2 polypeptide.

Toshiyuki Fukao1, Naoki Matsuo, Gai Xiu Zhang, Rintaro Urasawa, Tetsuo Kubo, Yoshinori Kohno, Naomi Kondo.   

Abstract

Initiator codon mutations are relatively uncommon and less well characterized compared to other types of mutations. We identified a novel initiator codon mutation (c.2T>C) heterozygously in a Japanese patient (Patient GK30) with mitochondrial acetoacetyl-CoA thiolase (T2) gene deficiency (ACAT1 deficiency); c.149delC was on the other allele. We examined translation efficiencies of nine mutant T2 cDNAs harboring one-base substitutions at the initiator methionine codon using in vivo transient expression analysis. We found that all the mutants produced wild-type T2 polypeptide, to various degrees (wild type (100%) > c.1A>C (66%) > c.2T>C, c.3G>C, c.3G>T (22%) > c3G>A, c.1A>G (11%) > c.2T>A, c.2T>G, c.1A>T (7.4%)). T2 mRNA expression levels in Patient GK08 (a homozygote of c.2T>A) and Patient GK30 fibroblasts, respectively, were almost the same as in control fibroblasts, when examined using semiquantitative PCR. This means that initiator codon mutations did not affect T2 mRNA levels. We propose that all one-base substitutions at the initiator methionine codon in the T2 gene could be mutations, which retain some residual T2 activity. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12754704     DOI: 10.1002/humu.10209

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  5 in total

1.  A single nucleotide substitution that abolishes the initiator methionine codon of the GLDC gene is prevalent among patients with glycine encephalopathy in Jerusalem.

Authors:  Avihu Boneh; Stanley H Korman; Kenichi Sato; Junko Kanno; Yoichi Matsubara; Israela Lerer; Ziva Ben-Neriah; Shigeo Kure
Journal:  J Hum Genet       Date:  2005-04-29       Impact factor: 3.172

2.  Characterization and outcome of 41 patients with beta-ketothiolase deficiency: 10 years' experience of a medical center in northern Vietnam.

Authors:  Khanh Ngoc Nguyen; Elsayed Abdelkreem; Roberto Colombo; Yuki Hasegawa; Ngoc Thi Bich Can; Thao Phuong Bui; Hai Thanh Le; Mai Thi Chi Tran; Hoan Thi Nguyen; Hung Thanh Trinh; Yuka Aoyama; Hideo Sasai; Seiji Yamaguchi; Toshiyuki Fukao; Dung Chi Vu
Journal:  J Inherit Metab Dis       Date:  2017-02-20       Impact factor: 4.982

3.  The mitochondrial acetoacetyl-CoA thiolase (T2) deficiency in Japanese patients: urinary organic acid and blood acylcarnitine profiles under stable conditions have subtle abnormalities in T2-deficient patients with some residual T2 activity.

Authors:  T Fukao; G X Zhang; N Sakura; T Kubo; H Yamaga; A Hazama; Y Kohno; N Matsuo; M Kondo; S Yamaguchi; Y Shigematsu; N Kondo
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

Review 4.  Ketone body metabolism and its defects.

Authors:  Toshiyuki Fukao; Grant Mitchell; Jörn Oliver Sass; Tomohiro Hori; Kenji Orii; Yuka Aoyama
Journal:  J Inherit Metab Dis       Date:  2014-04-08       Impact factor: 4.982

Review 5.  Mutation update on ACAT1 variants associated with mitochondrial acetoacetyl-CoA thiolase (T2) deficiency.

Authors:  Elsayed Abdelkreem; Rajesh K Harijan; Seiji Yamaguchi; Rikkert K Wierenga; Toshiyuki Fukao
Journal:  Hum Mutat       Date:  2019-07-03       Impact factor: 4.878

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.